Efficacy and Safety of Single-Dose Intravenous Ferric Carboxymaltose 1 g at 24 ± 1 Weeks of Gestation in Pregnant Women with Iron Deficiency Anaemia: A Prospective Interventional Study
International Journal of Science and Research (IJSR) · 15.07.2026 · 1028-1035
DOI: 10.21275/mr26713121758 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Science and Research (IJSR), erschienen am 15.07.2026. Verfasst von Ankita Girish Khiste und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Khiste, A. G., Gadappa, S. N., Bhingare, P. E., & Nair, K. P. (2026). Efficacy and Safety of Single-Dose Intravenous Ferric Carboxymaltose 1 g at 24 ± 1 Weeks of Gestation in Pregnant Women with Iron Deficiency Anaemia: A Prospective Interventional Study. International Journal of Science and Research (IJSR), 1028-1035. https://doi.org/10.21275/mr26713121758
Vancouver
Khiste AG, Gadappa SN, Bhingare PE, Nair KP. Efficacy and Safety of Single-Dose Intravenous Ferric Carboxymaltose 1 g at 24 ± 1 Weeks of Gestation in Pregnant Women with Iron Deficiency Anaemia: A Prospective Interventional Study. International Journal of Science and Research (IJSR). 2026:1028-1035. doi:10.21275/mr26713121758
BibTeX
@article{Khiste2026,
author = {Khiste, Ankita Girish and Gadappa, Shrinivas N and Bhingare, Prashant E and Nair, Kavya P},
title = {Efficacy and Safety of Single-Dose Intravenous Ferric Carboxymaltose 1 g at 24 ± 1 Weeks of Gestation in Pregnant Women with Iron Deficiency Anaemia: A Prospective Interventional Study},
journal = {International Journal of Science and Research (IJSR)},
year = {2026},
pages = {1028--1035},
doi = {10.21275/mr26713121758}
}
EUVIMED